Preliminary Biomarker Data from a Phase 1/2 Study of Golidocitinib Demonstrates Targeting JAK/STAT Pathway to Treat Peripheral T-Cell Lymphoma

Autor:	Song, Yuqin 1, Kim, Won-Seog 2, *, Yoon, Dok-Hyun 3, *, Yang, Haiyan 4, *, Cao, Junning 5, Ji, Dongmei 6, *, Koh, Youngil 7, Jing, Hongmei 8, Eom, Hyeon-Seok 9, *, Kwak, Jae-Yong 10, Lee, Won-Sik 11, Lee, Jong-Seok 12, *, Shin, Ho-Jin 13, *, Jin, Jie 14, Wang, Mei 15, *, Li, Jingrun 15, *, Zhu, Jun 16
Zdroj:	In Blood 15 November 2022 140 Supplement 1:6545-6546
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu